AbbVie (ABBV) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 2.83 | 2.27 | 2.75 | 4.18 | 3.62 | 3.53 | |||
| Changes by years, y/y, % | -23% | -20% | +21% | +52% | -13% | -0.3% | |||
AbbVie. Debt/EBITDA
AbbVie. Debt/EBITDA, changes, %
AbbVie (ABBV) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| Debt/EBITDA | 4.37 | 4.52 | 4.93 | 3.61 | 3.53 | 3.53 | ||
| Changes by years, y/y, % | +44% | +42% | +41% | -14% | -19% | |||
| Changes by quarters, q/q, % | +5% | +4% | +9% | -27% | -2% | |||